132 related articles for article (PubMed ID: 37389529)
1. Missed Opportunities for Adolescent Immunizations at Well-Care Visits During the COVID-19 Pandemic.
Kelly MK; Stephens-Shields AJ; Hannan C; Rand CM; Localio R; Shone LP; Steffes J; Davis K; Grundmeier RW; Humiston SG; Albertin C; McFarland G; Abney DE; Szilagyi PG; Fiks AG
J Adolesc Health; 2023 Sep; 73(3):595-598. PubMed ID: 37389529
[TBL] [Abstract][Full Text] [Related]
2. Missed opportunities for adolescent vaccination, 2006-2011.
Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
[TBL] [Abstract][Full Text] [Related]
3. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ
Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346
[TBL] [Abstract][Full Text] [Related]
4. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
5. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
6. A Multivariate Probit Regression of the Uptake of Adolescent Vaccines Among Racial/Ethnic Minority Adolescents Before and During the COVID-19 Pandemic.
Ejezie CL; Shegog R; Durand C; Cuccaro P; Savas LS
J Adolesc Health; 2024 Jan; 74(1):28-35. PubMed ID: 37804299
[TBL] [Abstract][Full Text] [Related]
7. Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics.
Pruitt SL; Tiro JA; Kepka D; Henry K
Am J Prev Med; 2022 Apr; 62(4):538-547. PubMed ID: 35125272
[TBL] [Abstract][Full Text] [Related]
8. Effect of provider prompts on adolescent immunization rates: a randomized trial.
Szilagyi PG; Serwint JR; Humiston SG; Rand CM; Schaffer S; Vincelli P; Dhepyasuwan N; Blumkin A; Albertin C; Curtis CR
Acad Pediatr; 2015; 15(2):149-57. PubMed ID: 25748976
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
[TBL] [Abstract][Full Text] [Related]
10. Effect of immunization registry-based provider reminder to initiate HPV vaccination at age 9, Washington state.
Christensen T; Zorn S; Bay K; Treend K; Averette C; Rhodes N
Hum Vaccin Immunother; 2023 Dec; 19(3):2274723. PubMed ID: 37929936
[TBL] [Abstract][Full Text] [Related]
11. A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016.
Irving SA; Groom HC; Dandamudi P; Daley MF; Donahue JG; Gee J; Hechter R; Jackson LA; Klein NP; Liles E; Myers TR; Stokley S
Vaccine; 2022 Feb; 40(9):1246-1252. PubMed ID: 35125221
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
Rivera L; Schwarz TF; Kim KH; Kim YK; Behre U; Cha SH; Jo DS; Lee J; Lee JS; Cheuvart B; Jastorff A; Van der Wielen M
Vaccine; 2018 Jul; 36(31):4750-4758. PubMed ID: 29960800
[TBL] [Abstract][Full Text] [Related]
13. Adolescent Vaccination Performance in South Carolina Compared to the United States.
Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702
[TBL] [Abstract][Full Text] [Related]
14. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
[TBL] [Abstract][Full Text] [Related]
15. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
Pingali C; Yankey D; Elam-Evans LD; Markowitz LE; Williams CL; Fredua B; McNamara LA; Stokley S; Singleton JA
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1183-1190. PubMed ID: 34473682
[TBL] [Abstract][Full Text] [Related]
16. Waning Tdap Effectiveness in Adolescents.
Klein NP; Bartlett J; Fireman B; Baxter R
Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
[TBL] [Abstract][Full Text] [Related]
17. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial.
Rivera L; Chanthavanich P; Põder A; Suryakiran PV; Jastorff A; Van der Wielen M
Vaccine; 2018 Jun; 36(27):3967-3975. PubMed ID: 29789243
[TBL] [Abstract][Full Text] [Related]
18. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(34):685-93. PubMed ID: 23985496
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth.
Setse RW; Siberry GK; Moss WJ; Wheeling J; Bohannon BA; Dominguez KL;
Pediatr Infect Dis J; 2016 May; 35(5):e152-7. PubMed ID: 26855409
[TBL] [Abstract][Full Text] [Related]
20. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.
Jackson ML; Yu O; Nelson JC; Nordin JD; Tartof SY; Klein NP; Donahue JG; Irving SA; Glanz JM; McNeil MM; Jackson LA
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):921-925. PubMed ID: 29862604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
